SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves selloff is being discussed alongside concerns about its heavy debt load, rising borrowing costs and whether AI demand and contract backlog can support its financing needs, with HSBCs bearish assessment adding to the pressure. Traders are split between viewing the balance-sheet risks and insider selling as reasons for further downside and arguing that strong demand, the backlog and Nvidia ties make the drop a buying opportunity.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders react to elevated crude prices and fears that Middle East shipping or energy-infrastructure attacks could disrupt supply, while weighing possible diplomacy and Russian supply relief. The community is split between bulls focused on geopolitical risk and bears expecting the risk premium to fade, with some also warning that contract-roll effects and an extended run may amplify volatility.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Lilly is drawing attention after breaking to a new high, with traders linking the rally to European regulatory backing for its Foundayo obesity pill and broader optimism about its GLP-1 business. Bulls are celebrating the breakout and healthcares defensive appeal, while skeptics point to possible profit-taking, competition from Novo and the upcoming earnings report.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is fueling a heavily bearish conversation, with traders tying its political-proxy appeal to concerns about Trumps approval and the midterms, while questioning the companys business traction. A smaller bullish contingent sees a possible trading bounce and points to the pending TAE fusion deal as a potential pivot.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers rebound toward a one-year high and the $30 level is driving discussion, with traders focused on whether the move can break through resistance. Some see momentum from a defensive-sector rotation and pipeline developments ahead of earnings, while others say the stock needs stronger news to sustain a breakout.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 RAP-219 trial in bipolar mania met its primary and secondary endpoints, drawing attention to the drugs potential but also to concerns about modest symptom improvement, agitation-related side effects, and discontinuations. Traders are divided, with some viewing the move as a fading bounce and adding shorts while others point to bullish analyst commentary.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is drawing attention after strong Q3 results and an upbeat outlook, with AI-related demand and growing Vertical Power Delivery royalty revenue reinforcing the growth story. Traders are weighing that strength against questions about one-time royalty catch-up payments, production capacity, and the earnings-per-share miss, contributing to a volatile reaction.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a sharp selloff across AI infrastructure and neocloud stocks as investors question whether heavy data-center spending and financing risks will generate adequate returns, with Gartners warning adding to the concern. Traders disagree on whether the pressure signals more downside or an oversold opportunity, with bulls pointing to IRENs contracted demand, power assets, and managements financing reassurances.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention for a sharp rebound after a tech-led selloff, which traders link to unconfirmed reports of potential U.S.-Iran talks and easing oil prices. The community is split between viewing the move as a bullish reversal and warning it may be a bull trap amid persistent volatility and concerns about tech and AI stocks.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

A semiconductor rebound after a prolonged selloff is driving attention, with traders debating whether the move signals a durable bottom or a temporary bounce amid lingering concerns about AI spending and valuations. Chip gains are part of a broader technology recovery ahead of major tech earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nomad Foods to Host an Analyst and Investor Day

Nomad Foods to Host an Analyst and Investor Day Nomad Foods to Host an Analyst and Investor DayPR NewswireWOKING, England, Oct. 6, 2026Raises 2026 Organic Revenue Outlook; Return to Growth Expected in the Third QuarterIntroduces Multi-Year Value Creation Plan Targeting Sustainable Revenue and...

Nomad Foods Announces Analyst and Investor Day

Nomad Foods Announces Analyst and Investor Day Nomad Foods Announces Analyst and Investor DayPR NewswireWOKING, England, Sept. 22, 2026 Members of Nomad Foods' Management Team to Present the Company's Multi-Year Growth Strategy in New York City on October 6, 2026WOKING, England, Sept. 22, 2026...

Nomad Foods to Present at the Barclays 19th Annual Global Consumer Staples Conference on September 9, 2026

Nomad Foods to Present at the Barclays 19th Annual Global Consumer Staples Conference on September 9, 2026 Nomad Foods to Present at the Barclays 19th Annual Global Consumer Staples Conference on September 9, 2026 PR Newswire WOKING, England, Sept. 3, 2026 WOKING, England, Sept. 3, 2026...

Nomad Foods CEO Brisby Buys $619,000 in NOMD Stock -- Here's Why Investors Should Take Note

Key PointsThe open-market acquisition of 50,000 shares represents a total transaction value of $619,000 at a weighted-average price of $12.38 per share...

Nomad Foods CFO Baldew Buys 28,290 Shares at $11.85 -- Should Investors Be Buying Too?

Key PointsRuben Baldew acquired 28,290 shares for $335,236.50 on Aug. 19, 2026...

Full Transcript: Nomad Foods Q2 2026 Earnings Call

Nomad Foods (NYSE:NOMD) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below.
This transcript is brought to you by Benzingaread more...

Nomad Foods (NOMD) Tops Q2 Earnings and Revenue Estimates

Nomad Foods (NOMD) delivered earnings and revenue surprises of +21.62% and +1.01%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nomad Foods Raises Prices, But Shoppers Buy Less

Nomad Foods stock slips as full-year earnings outlook is cut, despite beating Q2 EPS and revenue estimates. Get the full details here.read more...

Nomad Foods Reports Second Quarter 2026 Financial Results

Nomad Foods Reports Second Quarter 2026 Financial Results Nomad Foods Reports Second Quarter 2026 Financial Results PR Newswire WOKING, England, Aug. 13, 2026 Pricing and productivity drove a positive Adjusted Gross Margin inflectionCash generation remains strong with Adjusted Free Cash Flow...

Burcon NutraScience Corp (BRCNF) Reports Q1 Loss, Misses Revenue Estimates

Burcon NutraScience (BRCNF) delivered earnings and revenue surprises of -340.00% and -31.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nomad Foods Ltd. operates as a holding company, which manufactures and sells frozen foods for human consumption. Its products are offered under the brands LUTOSA, la Cocinera, Birds Eye, Iglo, and Findus. The company was founded by Noam Gottesman and Martin Ellis Franklin on April 1, 2014 and is headquartered in Woking, the United Kingdom.

Nomad Foods Limited

Nomad Foods’ Retail Sentiment Remains Subdued Despite Q4 Earnings Beat

Equity

Neutral Sentiment

Shares of frozen foods maker Nomad Foods (NOMD) rose 4.5% on Monday after the company posted better-than-expected fourth-quarter earnings, but retail sentiment and chatter remained subdued.Nomad’s revenue increased 4.3% to €793 million ($846.8 million) in Q4 compared to the same period last year, surpassing the estimate of €792.81 million. Its organic revenue growth came in at 3.1% and volume growth increased by 4.7%, said the company.Its Q4 earnings per share stood at EUR 0.42 ($0.46), beating estimates of $0.39.For the full year 2025, Nomad Foods expects organic revenue growth of 1% and 3% and Adjusted EBITDA growth of 2%-4%. &nbsp;Adjusted 2025 EPS is now expected to be €1.85-€1.89, reflecting growth of 4% and 6%, versus its prior outlook of €1.81 and €1.85."Our 2024 results demonstrate the impact of our focused brand investments and operational excellence, marking our ninth consecutive year of sales and Adjusted EBITDA growth. The investments we began to make in 2023 took hold and delivered strong returns in 2024, as evidenced by our accelerating volume momentum through the final three quarters and market share gains in each of the last two quarters of the year,” said CEO Stéfan Descheemaeker.Retail sentiment on Stocktwits for NOMD remained subdued and ended Monday in the ‘neutral’ zone with message volume in the ‘extremely low’ zone.<figure class="image"><img style="aspect-ratio:1326/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_04_at_12_59_33_PM_d9edd904c6.png" alt="Screenshot 2025-03-04 at 12.59.33 PM.png" width="1326" height="302"><figcaption>NOMD sentiment meter and message volume on March 4 as of 3 am ET</figcaption></figure>Following the results, Barclays raised the firm's price target to $23 from $19 with an ‘overweight’ rating, The Fly reported.Barclays said it models 2025 organic sales growth at the low end of the company's guidance range, as it expects Q1 to be well below this level, &nbsp;according to the report.Nomad Foods' portfolio includes such brands as Birds Eye, Findus, iglo, Ledo and Frikom.Nomad Foods stock is up 18.2% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Earnings per share stood at EUR 0.42 ($0.46), surpassing estimates of $0.39

Schwab Strategic Trust - Schwab Fundamental U.S. Small Company Index ETF

Vanguard Total World Stock ETF

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$11.93
Prev Close	$11.70
Open	$11.78
Dividend Yield	5.44%
50-Day Moving Average	$11.27
Beta	0.18
Avg. Volume	1.25M
PE Ratio	11.57

52-Week High	$13.08
52-Week Low	$8.99
Market Capitalization	$1.64B
EPS (Annual)	$1.03
Price to Book	0.57
Revenue Per Employee	$441,487.70

Feed

News

Sentiment

Earnings

Fundamentals

Info

NOMD Fundamentals